X0306 4 2021-05-18 0 0001831828 Vera Therapeutics, Inc. VERA 0001680200 Sofinnova Venture Partners X, L.P. C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 0 0 1 0 0001680194 Sofinnova Management X, L.L.C. C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 0 0 1 0 0001245624 HEALY JAMES C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 0 0 1 0 0001202793 POWELL MICHAEL C/O SOFINNOVA INVESTMENTS, INC. 3000 SAND HILL ROAD, BLDG. 4, SUITE 250 MENLO PARK CA 94025 0 0 1 0 Class A Common Stock 2021-05-18 4 C 0 2187504 A 2187504 D Class A Common Stock 2021-05-18 4 P 0 727272 11.00 A 2914776 D Series C Preferred Stock 2021-05-18 4 C 0 2187504 0.00 D Class A Common Stock 2187504 0 D The Series C Preferred Stock automatically converted into Class A Common Stock on a 11.5869:1 basis (on an adjusted basis, after giving effect to the reverse stock split of the Class A Common Stock effected by the Issuer on May 7, 2021) and had no expiration date. The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy, Maha Katabi, and Michael F. Powell are the managing members of SM X and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the Reporting Persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein. /s/ Nathalie Auber, as attorney-in-fact for Sofinnova Venture Partners X, L.P. 2021-05-18 /s/ Nathalie Auber, as attorney-in-fact for Sofinnova Management X, L.L.C. 2021-05-18 /s/ Nathalie Auber, as attorney-in-fact for James I. Healy 2021-05-18 /s/ Nathalie Auber, as attorney-in-fact for Michael F. Powell 2021-05-18